| Literature DB >> 28283223 |
Bharati Matta1, Su Song1, Dan Li1, Betsy J Barnes2.
Abstract
Interferon regulatory factors (IRFs) play critical roles in pathogen-induced innate immune responses and the subsequent induction of adaptive immune response. Dysregulation of IRF signaling is therefore thought to contribute to autoimmune disease pathogenesis. Indeed, numerous murine in vivo studies have documented protection from or enhanced susceptibility to particular autoimmune diseases in Irf-deficient mice. What has been lacking, however, is replication of these in vivo observations in primary immune cells from patients with autoimmune disease. These types of studies are essential as the majority of in vivo data support a protective role for IRFs in Irf-deficient mice, yet IRFs are often found to be overexpressed in patient immune cells. A significant body of work is beginning to emerge from both of these areas of study - mouse and human.Entities:
Keywords: Autoimmune disease; Cell signaling; Interferon regulatory factors; Pathogenesis
Mesh:
Substances:
Year: 2017 PMID: 28283223 PMCID: PMC8033540 DOI: 10.1016/j.cyto.2017.02.006
Source DB: PubMed Journal: Cytokine ISSN: 1043-4666 Impact factor: 3.861